Computer-aided discovery of dual-target compounds for Alzheimer’s from ayurvedic medicinal plants
PLOS One · 2025
DOI: 10.1371/journal.pone.0325441 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Mohibullah Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Alzheimer Disease, Plants, Medicinal, Medicine, Ayurvedic, Cholinesterase Inhibitors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by cognitive decline, driven by the accumulation of amyloid-beta plaques and neurofibrillary tangles. It involves the dysfunction of key enzymes such as Acetylcholinesterase (AChE) and β - secretase (BACE1), making them critical targets for therapeutic intervention. In this study we investigated an in-house library of 820 secondary metabolites obtained from Ayurvedic plants against AChE and BACE1 with the aim to discover novel leads for AD. Virtual screening resulted in 15 ligands, mostly belonging to the ursane-type or dammarene-type triterpene saponins of Centella asiatica, reestablishing the potency of this plant in drug discovery against AD. The binding affinities were further verified by molecular dynamics (MD) simulation trajectories, including root mean square fluctuations (RMSF), root mean square deviation (RMSD), hydrogen bonding analysis, Coulomb interaction calculation, Lennard-Jones interactions, and the total interaction energy. Moreover, extensive Principal Component Analysis (PCA) and Gibbs free energy landscape were performed. Our results demonstrated three compounds, namely (S)-eriodictyol 7-O-(6-β-O-trans-p-coumaroyl)-β-d-glucopyranoside, sitoindoside-X and 1,5-di-o-caffeoyl quinic acid as more effective in treating AD due to their comparable drug-like properties. Drug-likeness, structural chemistry, pharmacophore, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) analysis support their potential for future drug development. To establish the effectiveness of these lead compounds against AD, additional experimental testing should be performed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
- Department of Animal Science, Federal University of Ceara, Fortaleza, Brazil.
- Faculty of Veterinary Medicine, Postgraduate Program in Veterinary Sciences, State University of Ceara, Fortaleza, Brazil.
- Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia.
- Research Center for Advanced Materials Science (RCAMS), King Khalid University, AlQura'a, Abha, Saudi Arabia.
ORCID-Profile: Mohibullah Shah, Sibtain Ahmed, Umar Nishan
Zitieren
APA
Shah, M., Pervaiz, S., Ahmad, I., Ansari, S. H., Junior, V. F. P., Ahmed, S., Khan, M. U., Fawy, K. F., Nishan, U., Dib, H., & Abdelfattah, M. A. O. (2025). Computer-aided discovery of dual-target compounds for Alzheimer’s from ayurvedic medicinal plants. PLOS One. https://doi.org/10.1371/journal.pone.0325441
Vancouver
Shah M, Pervaiz S, Ahmad I, Ansari SH, Junior VFP, Ahmed S, et al. Computer-aided discovery of dual-target compounds for Alzheimer’s from ayurvedic medicinal plants. PLOS One. 2025. doi:10.1371/journal.pone.0325441
BibTeX
@article{Shah2025,
author = {Shah, Mohibullah and Pervaiz, Sadia and Ahmad, Iqra and Ansari, Shahid Habib and Junior, Valdir Ferreira De Paula and Ahmed, Sibtain and Khan, Muhammed Umer and Fawy, Khaled Fahmi and Nishan, Umar and Dib, Hanna and Abdelfattah, Mohamed A O},
title = {Computer-aided discovery of dual-target compounds for Alzheimer’s from ayurvedic medicinal plants},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0325441}
}
EUVIMED